136 related articles for article (PubMed ID: 11765217)
21. Co-oxidation of 2-bromohydroquinone by renal prostaglandin synthase. Modulation of prostaglandin synthesis by 2-bromohydroquinone and glutathione.
Lau SS; Monks TJ
Drug Metab Dispos; 1987; 15(6):801-7. PubMed ID: 2893705
[TBL] [Abstract][Full Text] [Related]
22. Identification of a genotoxic mechanism for 2-nitroanisole carcinogenicity and of its carcinogenic potential for humans.
Stiborová M; Miksanová M; Smrcek S; Bieler CA; Breuer A; Klokow KA; Schmeiser HH; Frei E
Carcinogenesis; 2004 May; 25(5):833-40. PubMed ID: 14729594
[TBL] [Abstract][Full Text] [Related]
23. Reactive intermediates formed during the peroxidative oxidation of anisidine isomers.
Thompson DC; Eling TE
Chem Res Toxicol; 1991; 4(4):474-81. PubMed ID: 1912336
[TBL] [Abstract][Full Text] [Related]
24. Prostaglandin H synthase-medicated oxidation and binding to DNA of a detoxication metabolite of carcinogenic Sudan I, 1-(phenylazo)-2,6-dihydroxynaphthalene.
Stiborová M; Schmeiser HH; Frei E
Cancer Lett; 1999 Nov; 146(1):53-60. PubMed ID: 10656609
[TBL] [Abstract][Full Text] [Related]
25. Tissue distribution, excretion and metabolism of o-anisidine in rats.
Sapota A; Czerski B; Jedrzejczak M
Int J Occup Med Environ Health; 2003; 16(4):351-7. PubMed ID: 14964645
[TBL] [Abstract][Full Text] [Related]
26. Prostaglandin hydroperoxidase-mediated 2-amino-4-(5-nitro-2-furyl) [14C]thiazole metabolism and nucleic acid binding.
Mattammal MB; Zenser TV; Davis BB
Cancer Res; 1981 Dec; 41(12 Pt 1):4961-6. PubMed ID: 6796263
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of formation and 32P-postlabeling of DNA adducts derived from peroxidative activation of carcinogenic non-aminoazo dye 1-phenylazo-2-hydroxynaphthalene (Sudan I).
Stiborová M; Frei E; Schmeiser HH; Wiessler M; Hradec J
Carcinogenesis; 1990 Oct; 11(10):1843-8. PubMed ID: 2208598
[TBL] [Abstract][Full Text] [Related]
28. Mutagenicity of o-anisidine to the bladder of lacI- transgenic B6C3F1 mice: absence of 14C or 32P bladder DNA adduction.
Ashby J; Short JM; Jones NJ; Lefevre PA; Provost GS; Rogers BJ; Martin EA; Parry JM; Burnette K; Glickman BW
Carcinogenesis; 1994 Oct; 15(10):2291-6. PubMed ID: 7955069
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the involvement of human N-acetyltransferase 1 in the genotoxic activation of bladder carcinogenic arylamines using a SOS/umu assay system.
Oda Y
Mutat Res; 2004 Oct; 554(1-2):399-406. PubMed ID: 15450435
[TBL] [Abstract][Full Text] [Related]
30. N'-(3'-monophospho-deoxyguanosin-8-yl)-N-acetylbenzidine formation by peroxidative metabolism.
Lakshmi VM; Zenser TV; Davis BB
Carcinogenesis; 1998 May; 19(5):911-7. PubMed ID: 9635882
[TBL] [Abstract][Full Text] [Related]
31. In vitro biotransformation and genotoxicity of the drinking water disinfection byproduct bromodichloromethane: DNA binding mediated by glutathione transferase theta 1-1.
Ross MK; Pegram RA
Toxicol Appl Pharmacol; 2004 Mar; 195(2):166-81. PubMed ID: 14998683
[TBL] [Abstract][Full Text] [Related]
32. Effect of peroxidase inhibitors on an in vivo metabolite of the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
Rice JR; Spry LA; Zenser TV; Davis BB
Cancer Res; 1988 Jan; 48(2):304-9. PubMed ID: 3121171
[TBL] [Abstract][Full Text] [Related]
33. Rat microsomes activating the anticancer drug ellipticine to species covalently binding to deoxyguanosine in DNA are a suitable model mimicking ellipticine bioactivation in humans.
Stiborová M; Stiborová-Rupertová M; Borek-Dohalská L; Wiessler M; Frei E
Chem Res Toxicol; 2003 Jan; 16(1):38-47. PubMed ID: 12693029
[TBL] [Abstract][Full Text] [Related]
34. Evidence for peroxidase-mediated metabolism of cyclophosphamide.
Kanekal S; Kehrer JP
Drug Metab Dispos; 1993; 21(1):37-42. PubMed ID: 8095224
[TBL] [Abstract][Full Text] [Related]
35. Prostaglandin H synthase-catalyzed activation of benzidine: a model to assess pharmacologic intervention of the initiation of chemical carcinogenesis.
Zenser TV; Mattammal MB; Wise RW; Rice JR; Davis BB
J Pharmacol Exp Ther; 1983 Dec; 227(3):545-50. PubMed ID: 6418878
[TBL] [Abstract][Full Text] [Related]
36. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
[TBL] [Abstract][Full Text] [Related]
37. Ochratoxin A: lack of formation of covalent DNA adducts.
Mally A; Zepnik H; Wanek P; Eder E; Dingley K; Ihmels H; Völkel W; Dekant W
Chem Res Toxicol; 2004 Feb; 17(2):234-42. PubMed ID: 14967011
[TBL] [Abstract][Full Text] [Related]
38. Metabolic activation of the carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide by prostaglandin H synthase.
Zenser TV; Palmier MO; Mattammal MB; Davis BB
Carcinogenesis; 1984 Oct; 5(10):1225-30. PubMed ID: 6435896
[TBL] [Abstract][Full Text] [Related]
39. An oxygen-bonded c8-deoxyguanosine nucleoside adduct of pentachlorophenol by peroxidase activation: evidence for ambident c8 reactivity by phenoxyl radicals.
Dai J; Wright MW; Manderville RA
Chem Res Toxicol; 2003 Jul; 16(7):817-21. PubMed ID: 12870883
[TBL] [Abstract][Full Text] [Related]
40. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
